Brokerages Expect Xylem Inc (NYSE:XYL) Will Post Quarterly Sales of $999.71 Million

Wall Street brokerages predict that Xylem Inc (NYSE:XYL) will post sales of $999.71 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Xylem’s earnings, with the lowest sales estimate coming in at $961.00 million and the highest estimate coming in at $1.05 billion. Xylem reported sales of $1.35 billion in the same quarter last year, which indicates a negative year over year growth rate of 25.9%. The firm is scheduled to announce its next earnings results on Thursday, August 6th.

On average, analysts expect that Xylem will report full year sales of $4.63 billion for the current year, with estimates ranging from $4.33 billion to $5.41 billion. For the next financial year, analysts anticipate that the business will post sales of $5.03 billion, with estimates ranging from $4.72 billion to $5.68 billion. Zacks’ sales averages are an average based on a survey of analysts that follow Xylem.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, May 5th. The industrial products company reported $0.23 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.37 by ($0.14). Xylem had a return on equity of 17.08% and a net margin of 7.01%. The firm had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same period last year, the company posted $0.52 earnings per share. The business’s revenue was down 9.2% compared to the same quarter last year.

XYL has been the topic of several analyst reports. Zacks Investment Research lowered shares of Xylem from a “hold” rating to a “sell” rating and set a $73.00 price target on the stock. in a research report on Monday, April 27th. Stifel Nicolaus dropped their price target on shares of Xylem from $87.00 to $79.00 and set a “buy” rating on the stock in a research report on Tuesday, April 21st. Berenberg Bank raised shares of Xylem from a “sell” rating to a “hold” rating in a research report on Thursday, March 26th. Goldman Sachs Group lowered shares of Xylem from a “neutral” rating to a “sell” rating and dropped their price target for the stock from $77.00 to $56.00 in a research report on Wednesday, April 8th. Finally, Atlantic Securities lowered shares of Xylem from an “overweight” rating to a “neutral” rating and set a $75.00 price objective on the stock. in a research report on Tuesday, March 31st. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $68.43.

NYSE XYL traded up $1.00 on Friday, hitting $63.16. 3,189,624 shares of the stock were exchanged, compared to its average volume of 1,345,259. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.55 and a quick ratio of 1.19. The business’s fifty day moving average is $64.78 and its 200 day moving average is $73.37. Xylem has a 52 week low of $54.62 and a 52 week high of $89.34. The company has a market capitalization of $11.18 billion, a PE ratio of 31.74, a P/E/G ratio of 4.35 and a beta of 1.02.

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, May 27th. This represents a $1.04 annualized dividend and a dividend yield of 1.65%. Xylem’s dividend payout ratio (DPR) is presently 34.44%.

Several hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. grew its stake in Xylem by 15.9% during the first quarter. BlackRock Inc. now owns 16,296,299 shares of the industrial products company’s stock worth $1,061,377,000 after buying an additional 2,241,395 shares in the last quarter. Aristotle Capital Management LLC acquired a new stake in Xylem during the first quarter worth about $540,568,000. Parnassus Investments CA grew its stake in Xylem by 3.3% during the fourth quarter. Parnassus Investments CA now owns 6,748,915 shares of the industrial products company’s stock worth $531,747,000 after buying an additional 215,478 shares in the last quarter. Pictet Asset Management Ltd. grew its stake in Xylem by 10.1% during the fourth quarter. Pictet Asset Management Ltd. now owns 4,899,464 shares of the industrial products company’s stock worth $386,029,000 after buying an additional 449,036 shares in the last quarter. Finally, Norges Bank acquired a new stake in Xylem during the fourth quarter worth about $274,648,000. Institutional investors and hedge funds own 85.88% of the company’s stock.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Read More: Technical Indicators – What is a Golden Cross?

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.